Epsilon M&A Deal Report - IDmyk (now Eurofins ID Myk)
Transaction Multiples for the Valuation of Private Companies
Eurofins Scientific / IDmyk (now Eurofins ID Myk)
No EMAT :
67214
Announced Date :
16/01/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Eurofins Scientific
Target :
IDmyk (now Eurofins ID Myk)
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2000, IDmyk offers laboratory services in the detection, identification and molecular typing of microorganisms for the pharmaceutical industry. > Proprietary databases for sequence-based...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 37
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/04/2014 | Private Group led by Salvepar | S2A Group (now Asten Group) | France | * | 66994 |
| 25/06/2013 | Unimedic | Cross Pharma | Sweden | ** | 66901 |
Source: Epsilon Research / EMAT
